Pipeline
Platform Flexibility
With LION™’s unique ability to deliver genetic material and other molecules to cells for various disease states, HDT Bio is well-positioned to address additional indications expanding the possibilities for personalized medicine and disease prevention.
Continuous Innovation
Through constant innovation and by demonstrating the versatility and flexibility of the LION™ platform in various disease indications, HDT Bio is capitalizing on the immense market potential and establishing itself as a dynamic company dedicated to transforming healthcare.
Oncology
Because HDT Bio’s technology platform enables localized, T cell-mediated immunological memory responses, LION™ has the potential to treat or prevent cancer. We are currently developing disease specific antigens associated with breast, brain, prostate, pancreatic, and other cancers.
Infectious Diseases
HDT Bio’s COVID-19 vaccine has an exceptional safety profile and has been administered to over 6,000 patients. More recently, we have been developing vaccines to target numerous life-threatening infectious diseases, including Crimean-Congo hemorrhagic fever virus (CCHF), Nipah virus, HIV, and tuberculosis.